Company Analysis
Sign in

Nautilus Biotechnology, Inc. (NAUT)

Nasdaq: NAUT · Laboratory Analytical Instruments · Seattle, WA · filing with the SEC since 2020
Full chart Alerts Compare
Grade5.4
◀ Past 4.6● Present 6.1▶ Future 5.1
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Report filedFeb 26, 2026Feb 27, 2025Feb 28, 2024Feb 23, 2023Feb 24, 2022Mar 30, 2021
Research and development41,110,00050,477,00047,251,00037,672,00029,352,00012,432,000
General and administrative25,727,00030,999,00028,901,00025,946,00021,146,0003,312,000
Total operating expenses66,837,00081,476,00076,152,00063,618,00050,498,00015,744,000
Interest income (expense), net7,868,00010,780,00012,550,0005,816,000329,000·
Total non-operating income (expense)7,836,00010,696,00012,477,0005,694,000183,000125,000
Income tax expense000000
Net income-59,001,000-70,780,000-63,675,000-57,924,000-50,315,000-15,619,000
Net income to common shareholders-59,001,000-70,780,000-63,675,000-57,924,000-50,315,000-15,619,000
Earnings per share, basic-0.47-0.56-0.51-0.46-0.60-0.54
Earnings per share, diluted-0.47-0.56-0.51-0.46-0.60-0.54
Weighted average shares, basic126,256,583125,426,509124,919,144124,589,55584,464,08129,089,778
Weighted average shares, diluted126,256,583125,426,509124,919,144124,589,55584,464,08129,089,778
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton NAUT · research, not advice